{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:05:27Z","timestamp":1778108727271,"version":"3.51.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/cad.0000000000000050","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T11:32:03Z","timestamp":1387279923000},"page":"745-750","source":"Crossref","is-referenced-by-count":6,"title":["Nomegestrol acetate\/estradiol hormonal oral contraceptive and breast cancer risk"],"prefix":"10.1097","volume":"25","author":[{"given":"Lino","family":"Del Pup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Di Francia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fiorica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Mileto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolf E.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210203","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"R3-2-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004.","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/13625187.2012.715357","article-title":"Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies.","volume":"17","author":"Zhu","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.11167","article-title":"Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.","volume":"105","author":"Dumeaux","year":"2003","journal-title":"Int J Cancer"},{"key":"R8-2-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins.","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"R9-2-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.maturitas.2012.01.007","article-title":"The pharmacology of nomegestrol acetate.","volume":"71","author":"Ruan","year":"2012","journal-title":"Maturitas"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2012.07.001","article-title":"Pharmacokinetic profile of nomegestrol acetate and 17-estradiol after multiple and single dosing in healthy women.","volume":"87","author":"Gerrits","year":"2013","journal-title":"Contraception"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11532130-000000000-00000","article-title":"Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy.","volume":"70","author":"Lello","year":"2010","journal-title":"Drugs"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0032-1308999","article-title":"Proliferative effects of estradiol- or ethinylestradiol-P combinations on human breast cancer cells in an intermitted and a long-term regimen.","volume":"44","author":"Merki-Feld","year":"2012","journal-title":"Horm Metab Res"},{"key":"R14-2-20210203","first-page":"70","article-title":"Antiandrogenic properties of nomegestrol acetate.","volume":"45","author":"Duc","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"R16-2-20210203","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0960-0760(94)90170-8","article-title":"Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells.","volume":"50","author":"Botella","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0960-0760(95)00156-T","article-title":"Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nortestosterone derivatives on endometrial Ishikawa cells.","volume":"55","author":"Botella","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R18-2-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0960-0760(95)00171-U","article-title":"Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity.","volume":"55","author":"Catherino","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R19-2-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2007.02.002","article-title":"Progesterone receptor membrane component 1: an integrative review.","volume":"105","author":"Cahill","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R20-2-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","article-title":"Breast cancer risk in postmenopausal women using estradiol-P therapy.","volume":"113","author":"Lyytinen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R22-2-20210203","first-page":"2827","article-title":"Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.","volume":"25","author":"Chetrite","year":"2005","journal-title":"Anticancer Res"},{"key":"R23-2-20210203","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0960-0760(96)00094-5","article-title":"Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells.","volume":"58","author":"Chetrite","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R24-2-20210203","first-page":"4651","article-title":"Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines.","volume":"23","author":"Chetrite","year":"2003","journal-title":"Anticancer Res"},{"key":"R25-2-20210203","first-page":"3219","article-title":"Correlation of estrogen sulfotransferase activity and proliferation in normal and carcinomatous human breast: a hypothesis.","volume":"27","author":"Pasqualini","year":"2007","journal-title":"Anticancer Res"},{"key":"R26-2-20210203","first-page":"417","article-title":"Nomegestrol acetate is an anti-aromatase agent in human MCF-7aro breast cancer cells.","volume":"3","author":"Chetrite","year":"2010","journal-title":"Horm Mol Biol Clin Invest"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/0006-2952(86)90321-7","article-title":"Studies of the inactivation of human placental aromatase by 17 alpha-ethynyl-substituted 10 beta-hydroperoxy and related 19-nor steroids.","volume":"35","author":"Covey","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"R28-2-20210203","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0039-128X(87)90036-5","article-title":"Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation.","volume":"50","author":"Killinger","year":"1987","journal-title":"Steroids"},{"key":"R29-2-20210203","first-page":"2129","article-title":"The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.","volume":"28","author":"Pasqualini","year":"2008","journal-title":"Anticancer Res"},{"key":"R31-2-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0960-0760(02)00154-1","article-title":"On the inhibitory action of 29 drugs having side effect gynecomastia on estrogen production.","volume":"82","author":"Satoh","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R35-2-20210203","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0002-9378(98)70149-8","article-title":"Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in nonhuman primates (Macaca fascicularis).","volume":"179","author":"Williams","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R36-2-20210203","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/ATVBAHA.108.178004","article-title":"Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.","volume":"29","author":"Zerr-Fouineau","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R37-2-20210203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners oral contraception study.","volume":"335","author":"Hannaford","year":"2007","journal-title":"Br Med J"},{"key":"R38-2-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.contraception.2010.04.006","article-title":"Factors affecting mortality in a large cohort study with special reference to oral contraceptive use.","volume":"82","author":"Vessey","year":"2010","journal-title":"Contraception"},{"key":"R39-2-20210203","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/13625187.2010.504313","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.","volume":"15","author":"Duijkers","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R40-2-20210203","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception.","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"R41-2-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10911-013-9274-8","article-title":"Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.","volume":"18","author":"Hilakivi-Clarke","year":"2013","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"R42-2-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2004.11.004","article-title":"Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.","volume":"93","author":"Shields-Botella","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R43-2-20210203","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/09513590.2011.652717","article-title":"Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.","volume":"28","author":"Del Pup","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R45-2-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2012.01.017","article-title":"Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study.","volume":"72","author":"Del Pup","year":"2012","journal-title":"Maturitas"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0000000000000050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:01:22Z","timestamp":1620946882000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201408000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0000000000000050","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}